Systems of protocol review, quality assurance, and data audit

Cancer Chemotherapy and Pharmacology, Supplement

Volumn 42, Issue , 1998, Pages

  Weiss, Raymond B ^a,b,c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Cancer and Leukemia Group B   (United States)

^c Cancer and Leukemia Group B Central Office   (United States)

Author keywords

Cancer treatment; Cooperative groups; Quality assurance; US National Cancer Institute

Indexed keywords

CANCER RESEARCH; CANCER THERAPY; CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; INFORMATION PROCESSING; MEDICAL AUDIT; MEDICAL RECORD; PRIORITY JOURNAL; QUALITY CONTROL;

EID: 0031668020     PISSN: 09439404     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051087     Document Type: Conference Paper

References (10)

1. Anonymous (1994) What's behind the NSABP clash? Ann Oncol 5:481
2. Canellos GP, Anderson JR, Propert KJ, Nissen N, Cooper MR, Henderson ES, Green MR, Gottlieb A, Peterson BA (1992) Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 327:1478
3. Cheung N-KV, Lazarus H, Miraldi FD, Berger NA, Abramowsky CR, Saarinen UM, Spitzer T, Strandjord SE, Coccia PF (1992) Reassessment of patient response to monoclonal antibody 3F8. J Clin Oncol 10:671
4. Christian MC, McCabe MS, Korn EL, Abrams JS, Kaplan RS, Friedman MA (1995) The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project protocol B-06. N Engl J Med 333:1469
5. Dingell JD (1993) Shattuck lecture-Misconduct in medical research. N Engl J Med 328:1610
6. Federal Register (11 June, 1982) 47:25413
7. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei M for the Cancer and Leukemia Group B (1994) Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 331:896
8. Steward WP, Vantongelen K, Verweij J, Thomas D, van Osteroom AT (1993) Chemotherapy administration and data collection in an EORTC collaborative group-can we trust the results? Eur J Cancer 29A:943
9. Weiss RB, Vogelzang NJ, Peterson BA, Panasci LC, Carpenter JC, Gavigan M, Sartell K, Frei E, McIntyre OR (1993) A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B. JAMA 270:459
10. Wood WC, Budman DR, Korzun AH, Cooper MR, Younger J, Hart RD, Moore A, Ellerton JA, Norton L, Ferree CR, Ballow AC, Frei E, Henderson IC (1994) Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. N Engl J Med 330:1253